A new study published in Clinical Cardiology introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in ...

San Francisco, CA—Results of the randomized EUROMAX trial show that administering bivalirudin to STEMI patients en route to the hospital for primary PCI reduces the primary outcome of short-term death ...

When it comes to delivering timely treatment for patients experiencing myocardial infarction (MI), many hospitals are continuing to fall short of national guidelines, new research showed. Benchmarks ...

Please provide your email address to receive an email when new articles are posted on . Among patients who required interhospital transfer for STEMI, nearly 40% had cath lab activation times of less ...

Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in ...

Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says. STEMI (ST‐segment-elevation myocardial infarction) heart attacks have declined by nearly 50% during ...

Identifying an acute myocardial infarction on the 12-lead ECG is the most important thing you can learn in ECG interpretation. Time is muscle when treating heart attacks. Missing a ST segment ...

Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation ...

Lead augmented vector right (aVR) is a useful measure in the diagnosis of ST-segment elevation acute myocardial infarction (STEMI), indicates a new analysis of data from the HERO-2 trial. “Lead aVR is ...

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug ...

BARCELONA, SPAIN —Treatment with aldosterone antagonists started within 3 days of acute ST-segment elevation MI (STEMI) onset, along with standard therapy, appeared to lower the risk of death over the ...